The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Rummelt, Andreas, Dr
    Chief Executive born in June 1956
    Individual (2 offsprings)
    Officer
    2013-07-01 ~ now
    OF - director → CIF 0
  • 2
    Fliri, Hans Georg, Dr
    Managing Director born in November 1944
    Individual (6 offsprings)
    Officer
    2012-04-12 ~ now
    OF - director → CIF 0
    Dr Hans Georg Fliri
    Born in November 1944
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
Ceased 5
  • 1
    Williams, Kerry
    Individual (5 offsprings)
    Officer
    2012-04-12 ~ 2017-12-31
    OF - secretary → CIF 0
  • 2
    Saxby, Simon James Yvon
    Chief Executive born in February 1958
    Individual (2 offsprings)
    Officer
    2012-04-12 ~ 2013-02-28
    OF - director → CIF 0
  • 3
    Hurley, Peter Laurence
    Chartered Accountant born in February 1944
    Individual
    Officer
    2013-03-11 ~ 2017-12-05
    OF - director → CIF 0
  • 4
    Kerr, Simon Christopher
    Ceo born in August 1957
    Individual (3 offsprings)
    Officer
    2014-10-01 ~ 2019-03-19
    OF - director → CIF 0
  • 5
    Baker-munton, Nicola Jane
    Ceo born in April 1964
    Individual (2 offsprings)
    Officer
    2014-11-27 ~ 2023-05-12
    OF - director → CIF 0
parent relation
Company in focus

CYPRALIS LIMITED

Previous name
SELCIA PHARMA LIMITED - 2013-10-17
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
32023-01-01 ~ 2023-12-31
32022-01-01 ~ 2022-12-31
Intangible Assets
3,500 GBP2023-12-31
3,500 GBP2022-12-31
Debtors
Current
1,999 GBP2023-12-31
2,383 GBP2022-12-31
Cash at bank and in hand
402 GBP2023-12-31
7,912 GBP2022-12-31
Current Assets
2,401 GBP2023-12-31
10,295 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-1,133,646 GBP2023-12-31
-976,036 GBP2022-12-31
Net Current Assets/Liabilities
-1,131,245 GBP2023-12-31
-965,741 GBP2022-12-31
Total Assets Less Current Liabilities
-1,127,745 GBP2023-12-31
-962,241 GBP2022-12-31
Net Assets/Liabilities
-1,127,745 GBP2023-12-31
-962,241 GBP2022-12-31
Equity
Called up share capital
206,735 GBP2023-12-31
206,735 GBP2022-12-31
Share premium
2,314,435 GBP2023-12-31
2,314,435 GBP2022-12-31
Retained earnings (accumulated losses)
-3,648,915 GBP2023-12-31
-3,483,411 GBP2022-12-31
Equity
-1,127,745 GBP2023-12-31
-962,241 GBP2022-12-31
Intangible Assets - Gross Cost
Development expenditure
3,500 GBP2023-12-31
3,500 GBP2022-12-31
Intangible Assets
Development expenditure
3,500 GBP2023-12-31
3,500 GBP2022-12-31
Other Debtors
Current
1,886 GBP2023-12-31
2,270 GBP2022-12-31
Prepayments/Accrued Income
Current
113 GBP2023-12-31
113 GBP2022-12-31
Other Remaining Borrowings
Current
1,097,532 GBP2023-12-31
955,287 GBP2022-12-31
Trade Creditors/Trade Payables
Current
21,482 GBP2023-12-31
4,807 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
14,632 GBP2023-12-31
15,942 GBP2022-12-31
Creditors
Current
1,133,646 GBP2023-12-31
976,036 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
4,134,695 shares2023-12-31
4,134,695 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.052023-01-01 ~ 2023-12-31

Related profiles found in government register
  • CYPRALIS LIMITED
    Info
    SELCIA PHARMA LIMITED - 2013-10-17
    Registered number 08028515
    St Johns Innovation Centre, Cowley Road, Cambridge CB4 0WS
    Private Limited Company incorporated on 2012-04-12 (13 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-08-11
    CIF 0
  • CYPRALIS LIMITED
    S
    Registered number 08028515
    St Johns Innovation Centre, Cowley Road, Cambridge, England, CB4 0WS
    Limited in Cypralis Limited, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • Bridge End Orchard, 35 Bridge Street, Saffron Walden, England
    Dissolved corporate (4 parents)
    Equity (Company account)
    0 GBP2021-12-31
    Person with significant control
    2022-01-04 ~ dissolved
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.